The Efficacy of Reiki in the Treatment of Fibromyalgia
| ISRCTN | ISRCTN32552026 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN32552026 |
| ClinicalTrials.gov (NCT) | NCT00051428 |
| Protocol serial number | R21 AT001075 |
| Sponsor | National Center for Complementary and Alternative Medicine (NCCAM) - USA |
| Funder | National Center for Complementary and Alternative Medicine (NCCAM) - USA |
- Submission date
- 14/08/2004
- Registration date
- 21/09/2004
- Last edited
- 25/01/2019
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Dedra Buchwald
Scientific
Scientific
University of Washington
Center for Clinical and Epidemiological Research
1730 Minor Ave., Suite 1760
Seattle
98101
United States of America
| Phone | +1 206 543 2260, +1 206 341 4439 |
|---|---|
| dedra@u.washington.edu |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | Reiki for the treatment of fibromyalgia: a randomized controlled trial |
| Study objectives | Not provided at time of registration |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Fibromyalgia (FM) |
| Intervention | One hundred Reiki-naive FM patients will participate in an 8-week trial. Patients will be randomized into one of two Reiki groups (direct-contact and distant Reiki) or one of two control groups (sham and placebo). Patients will receive either Reiki or placebo 16 times during the course of the study. |
| Intervention type | Other |
| Primary outcome measure(s) |
Not provided at time of registration |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 28/02/2005 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Upper age limit | 75 Years |
| Sex | All |
| Target sample size at registration | 100 |
| Key inclusion criteria | Male or Female, aged 18-75 with Fibromyalgia |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/01/2003 |
| Date of final enrolment | 28/02/2005 |
Locations
Countries of recruitment
- United States of America
Study participating centre
University of Washington
Seattle
98101
United States of America
98101
United States of America
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/11/2008 | 25/01/2019 | Yes | No |
Editorial Notes
25/01/2019: Publication reference added
